• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一家癌症医院接受广泛局部切除治疗并随访的隆突性皮肤纤维肉瘤:临床病理变量的预后意义

Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.

作者信息

Erdem Ozlem, Wyatt Angela J, Lin E, Wang Xuemei, Prieto Victor G

机构信息

Department of Pathology, Gazi University, Faculty of Medicine, Besevler, Ankara, Turkey.

出版信息

Am J Dermatopathol. 2012 Feb;34(1):24-34. doi: 10.1097/DAD.0b013e3182120671.

DOI:10.1097/DAD.0b013e3182120671
PMID:21785324
Abstract

Dermatofibrosarcoma protuberans (DFSP) is a relatively rare low-grade sarcoma. Local control can usually be achieved by wide local excision, but some patients still develop recurrences. The aim of this study was to investigate the correlation between clinicopathologic factors and recurrence-free survival (RFS)/overall survival (OS) in a large series of DFSP patients from a single institution. The study group included sections and medical records of 122 patients (63 women and 59 men, median age of 43) with primary DFSP from UT-MD Anderson Cancer Center between 1976 and 2005. Fibrosarcomatous change was detected in 24 (20.9%) patients. Thirty-eight of 120 patients (31.7%) recurred with a median RFS of 10.2 years. The 5-year RFS rate was 64.2%. Based on univariate analyses, fibrosarcomatous change, mitotic count, metastasis at time of diagnosis, and acral location were significantly associated with shorter RFS. On multivariate analysis, acral location and fibrosarcomatous change remained significant for shorter RFS. Five-year OS was 95.5% (95% confidence interval: 75.42%-99.3%). On univariate analysis, mitotic count per square millimeter, presence of necrosis, and metastasis at time of diagnosis were significantly associated with lower OS. On multivariate analysis, only presence of metastasis remained significantly associated with shorter OS. DFSP-FS variant and acral site are associated with shorter recurrence-free interval after wide local excision. Therefore, patients with tumors on acral sites or those with a fibrosarcomatous component may benefit from aggressive therapies other than wide local excision. The only factor that remains significantly associated with decreased OS is detection of metastasis.

摘要

隆突性皮肤纤维肉瘤(DFSP)是一种相对罕见的低级别肉瘤。通常可通过广泛局部切除实现局部控制,但部分患者仍会复发。本研究旨在调查来自单一机构的大量DFSP患者的临床病理因素与无复发生存期(RFS)/总生存期(OS)之间的相关性。研究组纳入了1976年至2005年间来自UT - MD安德森癌症中心的122例原发性DFSP患者(63例女性和59例男性,中位年龄43岁)的切片和病历。24例(20.9%)患者检测到纤维肉瘤样改变。120例患者中有38例(31.7%)复发,中位RFS为10.2年。5年RFS率为64.2%。单因素分析显示,纤维肉瘤样改变、核分裂象计数、诊断时的转移以及肢端部位与较短的RFS显著相关。多因素分析显示,肢端部位和纤维肉瘤样改变对较短的RFS仍具有显著意义。5年OS为95.5%(95%置信区间:75.42% - 99.3%)。单因素分析显示,每平方毫米核分裂象计数、坏死的存在以及诊断时的转移与较低的OS显著相关。多因素分析显示,仅转移的存在与较短的OS仍显著相关。DFSP - FS变异型和肢端部位与广泛局部切除后较短的无复发间期相关。因此,肢端部位有肿瘤或具有纤维肉瘤成分的患者可能从广泛局部切除以外的积极治疗中获益。与OS降低仍显著相关的唯一因素是转移的检测。

相似文献

1
Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.在一家癌症医院接受广泛局部切除治疗并随访的隆突性皮肤纤维肉瘤:临床病理变量的预后意义
Am J Dermatopathol. 2012 Feb;34(1):24-34. doi: 10.1097/DAD.0b013e3182120671.
2
Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.隆突性皮肤纤维肉瘤:对在单一机构接受治疗及随访的患者的临床病理分析
Cancer. 2000 Jun 15;88(12):2711-20.
3
Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.隆突性皮肤纤维肉瘤手术后的低复发率:来自单一机构的多学科方法。
Cancer. 2004 Mar 1;100(5):1008-16. doi: 10.1002/cncr.20051.
4
Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.纤维肉瘤样(“高级别”)隆突性皮肤纤维肉瘤:41例系列病例的临床病理及免疫组化研究,重点关注预后意义。
Am J Surg Pathol. 1998 May;22(5):576-87. doi: 10.1097/00000478-199805000-00009.
5
Acral dermatofibrosarcoma protuberans with metastases.伴有转移的肢端隆突性皮肤纤维肉瘤
Ann Plast Surg. 1999 Feb;42(2):217-20.
6
Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change.伴有纤维肉瘤样改变的隆突性皮肤纤维肉瘤的转移潜能。
J Surg Oncol. 2003 Mar;82(3):201-8. doi: 10.1002/jso.10211.
7
Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas.隆突性皮肤纤维肉瘤。一项重点关注纤维肉瘤区域的临床病理回顾。
Am J Surg Pathol. 1992 Oct;16(10):921-5.
8
Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.隆突性皮肤纤维肉瘤:29例采用莫氏显微外科手术治疗患者的报告及长期随访与文献复习
Cancer. 2004 Jul 1;101(1):28-38. doi: 10.1002/cncr.20316.
9
Outcomes of surgery for dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤的手术治疗结果。
Eur J Surg Oncol. 2004 Apr;30(3):341-5. doi: 10.1016/j.ejso.2003.12.005.
10
Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.隆突性皮肤纤维肉瘤:一项基于人群的癌症登记描述性研究,涉及1982年至2002年间连续诊断的66例病例。
J Eur Acad Dermatol Venereol. 2006 Nov;20(10):1237-42. doi: 10.1111/j.1468-3083.2006.01780.x.

引用本文的文献

1
A Case of Recurrent Dermatofibrosarcoma Protuberans With Fibrosarcomatous Transformation.一例复发性隆突性皮肤纤维肉瘤伴纤维肉瘤变病例。
Cureus. 2025 Aug 3;17(8):e89284. doi: 10.7759/cureus.89284. eCollection 2025 Aug.
2
Dermatofibrosarcoma protuberans in a pre-adolescent child.一名青春期前儿童的隆突性皮肤纤维肉瘤。
Int J Surg Case Rep. 2023 Sep;110:108761. doi: 10.1016/j.ijscr.2023.108761. Epub 2023 Aug 30.
3
Different sonographic presentations of dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤的不同超声表现。
J Ultrasound. 2024 Mar;27(1):61-65. doi: 10.1007/s40477-023-00796-2. Epub 2023 Jul 14.
4
Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls.隆突性皮肤纤维肉瘤的罕见变异型:临床、组织学及分子特征与诊断陷阱
Dermatopathology (Basel). 2023 Jan 29;10(1):54-62. doi: 10.3390/dermatopathology10010008.
5
Dermatofibrosarcoma protuberans of the hallux: A case report with review of the literature.拇趾隆突性皮肤纤维肉瘤:一例报告并文献复习
Int J Surg Case Rep. 2022 Jul;96:107325. doi: 10.1016/j.ijscr.2022.107325. Epub 2022 Jun 22.
6
Unmasking dermatofibrosarcoma protuberans: Case report of an atypical presentation complicated by post-surgical excision.隐匿性隆突性皮肤纤维肉瘤:一例非典型表现并术后切除并发症的病例报告
Int J Surg Case Rep. 2020;69:101-104. doi: 10.1016/j.ijscr.2020.03.020. Epub 2020 Apr 3.
7
Dermatofibrosarcoma protuberans, a rare but locally aggressive tumor on finger: clinical and aeromedical considerations.隆突性皮肤纤维肉瘤,一种罕见但局部侵袭性的手指肿瘤:临床及航空医学考量
Case Reports Plast Surg Hand Surg. 2015 Jan 6;2(1):15-8. doi: 10.3109/23320885.2014.995185. eCollection 2015.
8
Clinicopathological features of dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤的临床病理特征
Oncol Lett. 2016 Jan;11(1):661-667. doi: 10.3892/ol.2015.3966. Epub 2015 Nov 24.
9
Dermatofibrosarcoma protuberans with pit-like lesions: A case report and literature review.伴有凹陷样病变的隆突性皮肤纤维肉瘤:一例报告及文献复习
Oncol Lett. 2015 Dec;10(6):3765-3768. doi: 10.3892/ol.2015.3741. Epub 2015 Sep 24.
10
CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.CDKN2A/p16缺失表明CDK4是伊马替尼耐药性隆突性皮肤纤维肉瘤的治疗靶点。
Mol Cancer Ther. 2015 Jun;14(6):1346-53. doi: 10.1158/1535-7163.MCT-14-0793. Epub 2015 Apr 7.